Polymer segment represented more than 71% of the overall volume in 2018 owing to the design flexibility, easy availability, and durability of polymers.
Metal segment is likely to register a CAGR of more than 20% in terms of revenue from 2019 to 2023 on account of excellent sterilization and the ease of fabrication of metals to produce medical components.
The North-American biocompatible 3D printing materials market accounted for more than 46% of the overall revenue in 2018, owing to the significant investments in the medical industry, and the presence of medical device manufacturing bases in the US.
The biocompatible 3D printing materials market is moderately fragmented with a large number of players occupying the market share. In addition, the increase in strategic alliances is expected to impact the competitive landscape of this market.